宝济药业-B(02659)重磅发布:全球首创低敏IgG降解酶Ricefidase II期临床成功,为抗GBM病带来潜在首个药物疗法
Last Update:
6 6 月, 2026
Please share this article if you like it!
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.